Mavenclad

Boxed Warning — Mavenclad: Mavenclad may increase the risk of malignancy and is contraindicated in patients with a current malignancy. It also carries a risk of teratogenicity and is contraindicated in pregnant women and in patients of reproductive potential who do not plan to use effective contraception.

Mavenclad Warnings and Precautions

• Malignancy risk: Increased incidence of malignancy has been observed, particularly with additional treatment courses within 2 years of the initial two courses.
• Teratogenicity: Effective contraception is required during treatment and for a period after the last dose, for both women and men.
• Lymphopenia: Mavenclad can cause a significant reduction in lymphocyte counts; blood counts should be monitored before and during each treatment course.
• Infections: Increased risk of infections, including serious infections; screening for latent infections (such as tuberculosis and hepatitis) is recommended before starting treatment.
• Liver injury: Liver function should be monitored during treatment.

How to Access Mavenclad in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Mavenclad to India?

Mavenclad (cladribine) tablets may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified neurologist
• The patient's diagnostic reports confirming relapsing forms of multiple sclerosis
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Mavenclad available in India?

Mavenclad (cladribine tablets) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Mavenclad is not commercially marketed in India.

However, patients in India can legally access Mavenclad through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Mavenclad received US FDA approval in March 2019 for relapsing forms of multiple sclerosis, ensuring full transparency throughout the process.

Mavenclad can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Mavenclad

Mavenclad is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Mavenclad Across Major Cities in India

Named Patient Program supports access to Mavenclad for patients with relapsing forms of multiple sclerosis across major cities in India, coordinating documentation, sourcing, and delivery with treating neurologists.

Mumbai

Patients in Mumbai can access Mavenclad through NPP with support from treating neurologists at the city's leading MS care centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty neurology clinics to facilitate timely access to Mavenclad.

Bangalore

Bangalore's neurology centers work with NPP to support patients requiring Mavenclad.

Chennai

Patients in Chennai can access Mavenclad through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's neurology centers support diagnosis and access coordination for Mavenclad through NPP.

Kolkata

NPP facilitates access to Mavenclad for patients in Kolkata under the guidance of treating neurologists.

Pune

Patients in Pune can access Mavenclad through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Mavenclad for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Mavenclad through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Mavenclad for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Mavenclad through NPP with support from treating neurologists.

Lucknow

NPP facilitates access to Mavenclad for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Mavenclad through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Mavenclad for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.